Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Deloitte
Fuji
McKesson
Julphar
Merck
Farmers Insurance
Accenture
Cerilliant
Argus Health

Generated: October 17, 2017

DrugPatentWatch Database Preview

TALACEN Drug Profile

« Back to Dashboard

Which patents cover Talacen, and when can generic versions of Talacen launch?

Talacen is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in TALACEN is acetaminophen; pentazocine hydrochloride. There are sixty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the acetaminophen; pentazocine hydrochloride profile page.

Summary for Tradename: TALACEN

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list99
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TALACEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
TALACEN
acetaminophen; pentazocine hydrochloride
TABLET;ORAL018458-001Sep 23, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TALACEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
TALACEN
acetaminophen; pentazocine hydrochloride
TABLET;ORAL018458-001Sep 23, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Dow
Covington
Moodys
QuintilesIMS
Julphar
Baxter
Colorcon
Accenture
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot